TARA CAVAZOS: Open Payments
NPI 1235398249 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 13 payments from 5 companies in 2025. Trend: 2023 $74 · 2024 $171 · 2025 $250
Food & beverage: $217Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $148 |
| Recor Medical Inc | 1 | $41 |
| Corcept Therapeutics | 1 | $25 |
| Seqirus USA Inc | 1 | $22 |
| Astellas Pharma US Inc | 1 | $13 |
Products named: Wegovy, Paradise Ultrasound Renal Denervation System, Ozempic, Korlym, Fluad, Veozah.
Industry payments across TX — which companies pay providers there.
